- Anabasine
-
- $0.00 / 50mg
-
2025-04-30
- CAS:494-52-0
- Min. Order:
- Purity: 99.27%
- Supply Ability: 10g
- (-)-ANABASINE
-
- $30.00 / 1KG
-
2024-07-15
- CAS:494-52-0
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 200000KG
- Anabasine
-
- $1.00 / 1KG
-
2023-01-12
- CAS:494-52-0
- Min. Order: 0.5KG
- Purity: >99%
- Supply Ability: 20tons
|
| | (-)-ANABASINE Basic information |
| | (-)-ANABASINE Chemical Properties |
| | (-)-ANABASINE Usage And Synthesis |
| Chemical Properties | Pale Yellow Oil | | Uses | (S)-ANABASINE is used as a kind of Nicotinic receptor agonist. | | Uses | Anabasine occurs in the tobacco speciesNicotiana glauca, Anabasis aphylla L.,Chenopodiaceae, and Solanaceae. It is usedas an insecticide and as a metal anticorrosiveagent. | | Definition | ChEBI: The (S)-enantiomer of anabasine. | | Health Hazard | The acute toxic symptoms include increasedsalivation, confusion, disturbed vision, photophobia,nausea, vomiting, diarrhea, respiratorydistress, and convulsions. It causesrespiratory muscle stimulation similar to thatcaused by lobeline. An oral lethal dose indogs is 50 mg/kg. A subcutaneous lethaldose in guinea pigs is 10 mg/kg. | | Biological Activity | Anabasine ((S)-Anabasine) is an alkaloid, a component of tobacco. Anabasine is a botanical insecticide that acts as a pan-agonist of nicotinic acetylcholine receptors (nAChRs). Anabasine induces depolarization in TE671 cells endogenously expressing human myogenic nAChRs (EC50=0.7 μM). | | Safety Profile | Poison by ingestion,subcutaneous, and intravenous routes. Moderately toxicby skin contact. An experimental teratogen. Insecticide.Acute and subacute toxicity: increased salivation, vertigo,confusion, disturbed vision and hearing, photophobia,cold ext | | in vivo | Anabasine significantly reverses the impairment at the 0.2 mg/kg (p<0.05) and 2 mg/kg doses (p<0.025). Anabasine does not have any significant effects on response latency when administered alone. The 0.06 mg/kg Anabasine dose, in fact, significantly (p<0.05) exacerbates the dizocilpine-induced impairment. None of these Anabasine doses affects choice accuracy on their own. Individual dose comparisons show that the 0.06 mg/kg Anabasine dose plus dizocilpine (6.7±2.6) causes a significant (p<0.05) increase in non-response trials compare with dizocilpine alone (2.1±0.8). |
| | (-)-ANABASINE Preparation Products And Raw materials |
|